DLXY Delixy CEO cites rising crossborder delivery demand as key bright spot in latest quarterly earnings report Is Forte Biosciences FBRX stock respecting technical levels Q4 2025 Earnings Fall Short UONEK Urban One slips 042 after Q4 2025 earnings release with no consensus analyst estimate benchmarks